Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 12-Month High – Time to Buy?

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $10.03 and last traded at $9.9330, with a volume of 317412 shares. The stock had previously closed at $8.77.

Analyst Ratings Changes

Several research firms have issued reports on BAYRY. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 19th. Zacks Research downgraded shares of Bayer Aktiengesellschaft from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Bayer Aktiengesellschaft currently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Up 12.3%

The business’s fifty day moving average price is $8.07 and its two-hundred day moving average price is $7.89. The company has a debt-to-equity ratio of 1.04, a quick ratio of 0.73 and a current ratio of 1.13. The firm has a market capitalization of $38.71 billion, a P/E ratio of -10.15, a PEG ratio of 3.62 and a beta of 0.84.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.